Open Access Green as soon as Postprint is submitted to ZB.
Developing oxysterol inhibitors as a novel therapeutic target for iBALT driven chronic pulmonary diseases.
Am. J. Respir. Crit. Care Med. 199 (2019)
Publication type
Article: Journal article
Document type
Meeting abstract
ISSN (print) / ISBN
1073-449X
e-ISSN
1535-4970
Quellenangaben
Volume: 199
Publisher
American Thoracic Society
Publishing Place
25 Broadway, 18 Fl, New York, Ny 10004 Usa
Reviewing status
Peer reviewed
Institute(s)
Institute of Lung Health and Immunity (LHI)